Subjects: Neoplasms -- drug therapy / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Neoplasms -- drug therapy ✖ Copyright Public domain ✖

11. Oncology therapeutic radiopharmaceuticals: nonclinical studies and labeling recommendations

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
Subject(s):: Drug Evaluation, Preclinical -- standards
Neoplasms -- drug therapy
Radiopharmaceuticals -- pharmacology
Toxicity Tests
Carcinogenicity Tests
Drug Labeling
Lactation -- drug effects
Pharmacokinetics
Radiation Dosage
Animals
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

12. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
Subject(s):: Double-Blind Method
Neoplasms -- drug therapy
Placebos
Randomized Controlled Trials as Topic -- standards
Single-Blind Method
Antineoplastic Agents
Biological Products
Randomized Controlled Trials as Topic -- ethics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

13. Real-time oncology review (RTOR): guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, November 2023
Subject(s):: Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Neoplasms -- drug therapy
United States

14. Submitting patient-reported outcome data in cancer clinical trials: guidance for industry : technical specifications document

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, November 2023
Subject(s):: Clinical Trials as Topic
Drug Development
Drug Industry
Government Regulation
Neoplasms -- drug therapy
Patient Reported Outcome Measures
United States